Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh sold 7,245 shares of the firm’s stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $1.61, for a total value of $11,664.45. Following the sale, the chief executive officer now directly owns 2,385,201 shares of the company’s stock, valued at approximately $3,840,173.61. This trade represents a 0.30 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Vininder Singh also recently made the following trade(s):
- On Thursday, April 3rd, Vininder Singh sold 27,958 shares of Bullfrog AI stock. The stock was sold at an average price of $1.44, for a total value of $40,259.52.
Bullfrog AI Trading Down 14.0 %
BFRG traded down $0.23 on Thursday, hitting $1.41. The company had a trading volume of 319,460 shares, compared to its average volume of 318,890. The company’s fifty day moving average price is $2.31 and its 200 day moving average price is $2.35. Bullfrog AI Holdings, Inc. has a 1 year low of $1.38 and a 1 year high of $4.84. The firm has a market cap of $13.28 million, a P/E ratio of -1.66 and a beta of 0.33.
Institutional Trading of Bullfrog AI
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its position in shares of Bullfrog AI by 31.0% during the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after buying an additional 11,140 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Bullfrog AI in the 4th quarter valued at $30,000. Finally, Two Sigma Securities LLC acquired a new position in Bullfrog AI during the 4th quarter worth about $41,000. Hedge funds and other institutional investors own 0.96% of the company’s stock.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Stories
- Five stocks we like better than Bullfrog AI
- 3 REITs to Buy and Hold for the Long Term
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Quiet Period Expirations Explained
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.